Skip to main content

Collection: Hepatitis C

The 2020 Nobel Prize for Physiology or Medicine was awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of Hepatitis C virus. In celebration of what they started and showcasing areas of research that have since emerged, we here present a collection of articles from the BMC Biology, BMC Medicine, Genome Medicine and the BMC Series Journals on biology, diagnosis and treatment and wider public health and medical outcomes of the Hepatitis C virus and its infection.

BMC Series Focus Issues

November: Infection and health

The BMC Series journals would like to dedicate their November focus issue to the recent research into infections and health highlighting four key topics within research on infection - the biology, recent advances in detection and diagnosis, the risk factors and incidence reports and finally on the advances in treatment and combating of infection.  Browse the articles in the focus issue further to learn more.

October: Focus on Stem Cells

With Stem Cell Awareness day on the 13th October this year we have compiled an article collection from across different BMC Series journals covering aspects of basic stem cell biology; in vitro differentiation studies; stem-cell based therapy studies for various conditions in animal models; technical advancements and ethical issues. 

Featured articles

Adverse drug reactions in children

Can we use the Adverse Drug Event Report database for drug safety surveillance in Children? This study on the Japanese database evaluates. 

Can Statin combat antipsychotics-induced weight gain?

In this study in young rats, the authors test the efficacy of statin interventions and particularly, Simvastatin, in reversing second generation antipsychotics-induced dyslipidemia.

Articles

Aims and scope

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.

Peer Review Taxonomy

This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.

The following summary describes the peer review process for this journal:

  • Identity transparency: Single anonymized
  • Reviewer interacts with: Editor
  • Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.

Editor

Anne Menard, BioMed Central, UK
 

Assistant Editor

Catriona Leslie, BioMed Central, UK

Data support service

Authors submitting to this journal can opt to use a new service that will make it easier to share research data.

Find out more

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics